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Nausea is the most characteristic 
negative experience that typically 
accompanies toxin-induced illness. 
Because most plant-derived toxins 
taste bitter, there is a rational link 
between bitter tasting compounds 
in the mouth and nausea that often 
results from their ingestion. It is 
surprising then that there are no 
experimental data demonstrating 
this connection. There are, however, 
data consistent with this notion. For 
example, people who are the most 
sensitive to bitter stimuli are more 
prone to motion sickness [1], and 
bitter taste sensitivity and pregnancy 
associated nausea are positively 
related, a response postulated to 
protect the fetus from poisoning [2]. 
Moreover, we know that bitter taste 
slows gastric emptying, a correlate 
of nausea [3]. Bitter taste is strongly 
sensed by the glossopharyngeal and 
vagus nerves [4], which innervate 
the posterior oral cavity and the 
gastrointestinal tract, respectively. The 
two projection fields of these sensory 
nerves are immediately adjacent 
within the nucleus of the solitary tract 
as well as in other brain relays [5], 
thus establishing a neuro-anatomical 
substrate for taste inputs to influence 
gastrointestinal states. Here, we 
report the first direct demonstration 
that bitter taste stimulation, but not 
sweet, salty, or umami taste, induces 
nausea, showing that the body not 
only detects potential toxins but 
anticipates their ingestion by inducing 
a prophylactic aversive state.
The induction of perceived nausea 
was measured on a modified Muth 
Nausea Profile (MNP) [6] and by the 
physiological measure of gastric 
myoelectrical activity (GMA) by 
recording electrogastrograms (EGGs), 
which have long been used, both 
experimentally and clinically, to 
assess gastric correlates of nausea 
sensations [7]. The MNP questionnaire 
asks for ratings of nausea, as well as 
Correspondence 14 other feelings such as queasiness, weakness and gastric churning 
(see the Supplemental Information 
for details). GMA is modulated by 
activity from pacemaker areas of the 
stomach. Normal GMA oscillates at 
3 cycles per minute (cpm). During 
either physical illness or sensations 
of nausea, the pattern shifts and 
dysrhythmias (bradygastria, 1–2.5 
cpm, and tachygastria, 3.75–10 cpm) 
increase. Fast Fourier transform of the 
EGG signal enables the experimenter 
to determine the onset of nausea via 
shifts in the frequencies of GMA (see 
Figure 1E for power analyses) [8]. 
We asked 63 healthy subjects 
(fasted for four hours) to sample an 
intensely bitter, but non-toxic, solution 
(0.8 mM sucrose octa-acetate, SOA). 
The SOA solution was held in the 
mouth for three minutes and then 
expectorated. Overall, 20% of the 
subjects reported being strongly 
nauseated (MNP score > 45) by oral 
exposure to the bitter stimulus, 45% 
were mild to moderately nauseated 
(MNP score 45 to 15), and 35% 
did not experience any nausea or 
discomfort (MNP score < 15) (Figure 
1A). MNP scores provided by the 
subjects were not correlated with 
their perceived bitterness intensity 
(r2 = 0.06; Figure 1B), nor to their 
unpleasantness ratings of the solution 
(also r2 = 0.06; data not shown). 
Almost all the subjects rated the SOA 
solution as being very bitter and very 
unpleasant. Why some people report 
nausea and others do not to the same 
nauseogenic stimulus is unknown, but 
such diversity of nausea responses 
is ubiquitous. Studies demonstrate 
there is a genetic component to 
nausea susceptibility. In addition, 
anxiety, conditioning, adaptation 
and tendency to report bodily 
changes also may underlie individual 
differences in nausea susceptibility 
(see [9] for review). 
To determine whether the induced 
nausea was specific to SOA, we 
tested a different group of subjects 
(n = 12) with both SOA and a second 
bitter intensity-matched solution of 
quinine hydrochloride (also 0.8 mM), 
a natural alkaloid that is commonly 
employed as a bitter tasting 
stimulus. The same proportions of 
subjects as in the previous study 
reported being nauseated by SOA 
and quinine solutions (Figure 1C). 
Moreover, the nausea ratings in 
response to SOA and quinine were highly correlated (r2 = 0.93). We also 
asked a subset of subjects from the 
first experiment, those who were 
strongly SOA-nauseated (n = 12) and 
half of those who were not (n = 11), 
to perform the same sensory test 
with a sweet sucrose solution (2.0 
M sucrose) that had been intensity 
matched to SOA (see Supplemental 
Information). In this case, none of 
the subjects reported being strongly 
nauseated by the exposure to the 
sweet stimulus and 70% reported no 
discomfort (data not shown). To test 
further the specificity of bitter taste 
for nausea induction, we employed 
another aversive taste stimulus, 1.0 M 
monosodium glutamate (MSG), which 
tastes strongly umami and moderately 
salty and is considered the most 
unpleasant taste stimulus after 
bitterness at this high concentration. 
In contrast to the two bitter stimuli, 
the nausea ratings of SOA and 1.0 M 
MSG were uncorrelated (r2 = 0.002;  
n = 7). Five of seven subjects reported 
no nausea from MSG and two 
reported mild to moderate nausea, 
ratings considerably lower than their 
responses to SOA (data not shown).
During the sessions, subjects 
were connected to EGG electrodes. 
The first 13 minutes of recording 
established baseline GMA. 
Afterwards, subjects rinsed, gargled 
and expectorated either the bitter 
SOA or the sweet stimulus for three 
minutes followed by 15 minutes of 
EGG recording. As a reference for 
shifts in GMA occurring during the 
onset of nausea, 13 subjects were 
exposed to an opto-kinetic drum, 
painted inside with alternating white 
and black vertical stripes, that rotated 
around their head and upper body 
at 10 rpm while nothing was held in 
the mouth. The opto-kinetic drum 
provides a kinetic visual stimulus for 
the subject and is commonly used in 
motion sickness research to induce 
nausea through apparent motion. 
Among the 13 subjects tested, all 
except one reported on the MNP 
being strongly nauseated by the 
rotating drum. Figure 1D shows the 
analysis of EGG data obtained during 
these sessions for all the subjects 
(mean ± SEM). The values on the 
graph represent the amount of normal 
(3 cpm) and dysrhythmic (1–2.5 
cpm and 4–9 cpm) gastric activity 
recorded during the rotation period 
divided by the amount of gastric 
activity recorded during the baseline 
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R248Figure 1. Bitter taste selectively induces nausea and dysrhythmia of gastric myoelectrical activity.
(A) Muth Nausea Profile (MNP) scores of 63 subjects after tasting the bitter stimulus 
sucrose octa-acetate (SOA). (B) Bitterness intensity ratings (10 point scale) vs MNP scores after 
tasting SOA. Arrow indicates mean bitterness. (C) MNP scores to equi-bitter SOA vs 
quinine-HCl, tested randomly on different days (n = 12). 25% were strongly nauseated by 
SOA and quinine (black circles), 42% were mildly nauseated (grey circles), and 33% were 
not nauseated (open circles). (D) The shifts in gastric myoelectrical activity (GMA) are depicted 
at the onset of nausea, provoked by the potent nauseogenic rotating opto-kinetic drum 
(n = 13). Change in GMA is shown between the pre-stimulus period (drum not rotating) 
and the post-stimulus period (drum rotating) in dysrhythmia and normal frequency ranges 
(mean ± SEM). Values were natural log transformed (zero represents no change). Compare 
this to the shift observed with bitter taste-induced nausea (Panel F, far left). (E) Representative 
spectral analyses of EGG signal Fast Fourier transforms, recorded during bitter taste (SOA) 
exposure in a strongly nauseated subject (MNP > 45) (left) and sweet taste exposure (right). 
X-axis represents GMA frequency (cycle per minute, cpm), Y-axis represents time (one minute 
intervals between the lines); bold lines indicate taste exposures), and the Z-axis represents 
GMA power. The first five minutes of EGG recording after stimulus exposure were analyzed. 
(F) Shifts in GMA activity, plot as in Panel D, when tasting SOA (left) and sucrose (right) 
[mean ± SEM].  23 subjects were tested (12 nauseated by SOA; 11 non-nauseated by SOA). 
Asterisk: p < 0.05.period (when drum is not rotating). 
As expected, GMA increased at all 
frequencies during nausea onset 
(drum rotation), but most notably 
in the dysrhythmic range. This 
establishes the pattern of activity for 
a potent, stereotypical nauseogenic 
stimulus against which the pattern of 
nausea-related activity to SOA should
be compared (Figure 1F, lower left). 
The EGG data from the taste 
sessions (see Figure 1E for 
representative traces) were analyzed 
similarly. Taste-related EGG data  
in Figure 1F were segregated into  
two categories, an SOA nauseated 
group (n = 12; far left) and an SOA 
non-nauseated group (n = 11; near 
left) based on the individual’s  
post-stimulus MNP scores (Figure 
1A). The changes in GMA occurring 
immediately after oral exposure 
to SOA are similar to the ones 
induced by the opto-kinetic drum: a 
marked and significant increase in 
dysrhythmia occurred, but only in the
SOA nauseated group. No changes 
occurred in the SOA non-nauseated 
group (p < 0.05; Figure 1F, near left  
 
panel). If any change to SOA can be 
observed in this group, there was a 
slight decrease in the overall level of 
gastric activity, which also represents 
the response to oral sucrose exposure 
in both groups (Figure 1F, right panel). 
Hence, exposure to a bitter 
stimulus in the SOA nauseated group 
significantly increased their gastric 
dysrhythmia (p < 0.05), whereas a 
sweet stimulus had no such effect. 
Therefore, GMA correlates with a 
subject’s nausea self-assessment 
and confirms that oral exposure to 
a bitter tasting stimulus can induce 
nausea in healthy participants. Such 
a direct link between oral exposure 
to bitter stimuli and nausea elicitation 
has not been established previously. 
We believe this work, complementary 
to and extending Wicks et al. [3], 
demonstrates that there are, in 
addition to appetitive anticipatory 
responses to nutrients preparing the 
body to digest food and reward its 
ingestion [10], aversive anticipatory 
responses that prepare the body 
to contain, repel, and punish our 
ingestion of anti-nutrients or toxins.Supplemental Information
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